Yuehua Li Selected Research

Yuehua Li Research Topics

Disease

21	Neoplasms (Cancer) 10/2022 - 12/2011
13	Inflammation (Inflammations) 01/2021 - 05/2007
9	Cardiomegaly (Heart Hypertrophy) 01/2016 - 10/2004
8	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2017
8	Hemorrhagic Shock 01/2015 - 05/2007
7	Ischemic Stroke 08/2022 - 05/2008
7	Stroke (Strokes) 02/2022 - 05/2008
6	Sepsis (Septicemia) 10/2022 - 12/2009
6	Neoplasm Metastasis (Metastasis) 06/2021 - 07/2016
5	Wounds and Injuries (Trauma) 11/2017 - 12/2009
4	Body Weight (Weight, Body) 01/2018 - 10/2004
4	Fibrosis (Cirrhosis) 12/2017 - 03/2006
4	Ischemia 01/2016 - 05/2007
3	Atherosclerosis 01/2022 - 02/2013
3	Acute Lung Injury 12/2021 - 12/2009
3	Pathologic Constriction (Stenosis) 06/2021 - 01/2018
3	Carcinogenesis 01/2021 - 07/2016
3	Endolymphatic Hydrops 10/2020 - 02/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 05/2009
3	Pneumonia (Pneumonitis) 01/2020 - 08/2007
3	Hypoxia (Hypoxemia) 07/2019 - 01/2017
3	Reperfusion Injury 01/2017 - 05/2009
3	Shock 03/2011 - 04/2006
2	Liver Neoplasms (Liver Cancer) 07/2022 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2021
2	Thrombosis (Thrombus) 02/2022 - 01/2021
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 07/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2020
2	Type 2 Diabetes Mellitus (MODY) 05/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2009
2	Cerebral Infarction 01/2020 - 05/2008
2	Infections 01/2020 - 01/2020
2	Obesity 11/2019 - 07/2016
2	Infarction (Infarctions) 05/2018 - 09/2009
2	AIDS-Related Complex (ARC) 01/2018 - 09/2017
2	Insulin Resistance 01/2017 - 01/2013
2	Myocardial Infarction 01/2017 - 11/2012
2	Coronary Disease (Coronary Heart Disease) 01/2017 - 06/2013
2	Hypertrophy 01/2016 - 05/2015
2	Cardiomyopathies (Cardiomyopathy) 07/2015 - 05/2015
2	Optic Nerve Injuries 07/2014 - 07/2011
2	Hemorrhage 12/2009 - 05/2007

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
8	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2015
7	Long Noncoding RNAIBA 01/2022 - 06/2017
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2013
7	CytokinesIBA 01/2021 - 08/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 05/2007
6	NF-kappa B (NF-kB)IBA 12/2009 - 10/2004
5	InflammasomesIBA 04/2022 - 11/2011
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 12/2009
5	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2017 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Nucleic AcidsIBA 01/2022 - 10/2020
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2021 - 12/2015
4	Sirtuin 1IBA 07/2019 - 01/2017
4	salicylhydroxamic acid (SHAM)IBA 07/2011 - 10/2004
3	Biological ProductsIBA 07/2022 - 01/2020
3	Circular RNAIBA 01/2021 - 01/2020
3	Therapeutic UsesIBA 01/2021 - 07/2011
3	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2020 - 02/2013
3	CollagenIBA 12/2017 - 04/2014
3	Phosphotransferases (Kinase)IBA 01/2016 - 07/2014
3	LigandsIBA 11/2014 - 05/2007
2	Interleukin-33IBA 10/2022 - 01/2018
2	FibrinIBA 02/2022 - 01/2021
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 03/2021
2	polyethylene glycol polyethyleneimine nanogelIBA 01/2022 - 07/2021
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 12/2005
2	LeptinIBA 01/2022 - 07/2016
2	AntioxidantsIBA 01/2021 - 10/2004
2	AntigensIBA 10/2020 - 10/2004
2	Glycerol (Glycerine)FDA LinkGeneric 10/2020 - 01/2018
2	LipopolysaccharidesIBA 01/2020 - 12/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 08/2012
2	Retinaldehyde (Retinal)IBA 07/2019 - 01/2019
2	CalciumIBA 01/2018 - 09/2017
2	NucleotidesIBA 01/2018 - 11/2014
2	Estrogens (Estrogen)FDA Link 01/2018 - 08/2009
2	SolutionsIBA 09/2017 - 05/2015
2	Histones (Histone)IBA 01/2017 - 01/2017
2	HSP27 Heat-Shock ProteinsIBA 01/2016 - 07/2015
2	EndotoxinsIBA 12/2015 - 05/2007
2	Angiopoietin-1IBA 04/2015 - 11/2012
2	ChemokinesIBA 07/2013 - 08/2007
2	NADP (NADPH)IBA 03/2011 - 08/2007
2	HMGB1 Protein (HMG1)IBA 12/2009 - 05/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2007 - 11/2005
2	prolinedithiocarbamate (PDTC)IBA 12/2005 - 10/2004

Therapy/Procedure

9	Therapeutics 08/2022 - 02/2014
5	Resuscitation 11/2014 - 05/2007
3	Punctures 10/2022 - 01/2018
3	Ligation 10/2022 - 01/2018
3	Stents 02/2022 - 06/2018
3	Thrombectomy 02/2022 - 01/2021
2	Immunotherapy 07/2021 - 01/2020
2	Intraperitoneal Injections 01/2021 - 07/2014
2	Drug Therapy (Chemotherapy) 05/2020 - 02/2018
2	Radiotherapy 01/2020 - 12/2011